Needham analyst Joshua Reilly downgrades ChannelAdvisor (NYSE:ECOM) from Buy to Hold.
Expert Ratings for Enanta Pharma
Analysts have provided the following ratings for Enanta Pharma (NASDAQ:ENTA) within the last quarter: Bullish Somewhat Bullish Indifferent…